Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -36.20 |
| peg ratio | 0.42 |
| price to book ratio | 3.34 |
| price to sales ratio | 177.71 |
| enterprise value multiple | -27.68 |
| price fair value | 3.34 |
profitability ratios | |
|---|---|
| gross profit margin | 87.98% |
| operating profit margin | -658.76% |
| pretax profit margin | -463.91% |
| net profit margin | -463.91% |
| return on assets | -8.71% |
| return on equity | -10.46% |
| return on capital employed | -12.68% |
liquidity ratio | |
|---|---|
| current ratio | 38.80 |
| quick ratio | 38.80 |
| cash ratio | 1.56 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 572.74 |
| cash conversion cycle | -572.74 |
| receivables turnover | 0.00 |
| payables turnover | 0.64 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | -26.25 |
| cash flow to debt ratio | -1.58 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.69 |
| cash per share | 12.05 |
| operating cash flow per share | -0.68 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -1.58 |
| short term coverage ratios | -21.90 |
| capital expenditure coverage ratio | -44.46 |
Frequently Asked Questions
Janux Therapeutics, Inc. (JANX) published its most recent earnings results on 06-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Janux Therapeutics, Inc. (NASDAQ:JANX)'s trailing twelve months ROE is -10.46%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Janux Therapeutics, Inc. (JANX) currently has a ROA of -8.71%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
JANX reported a profit margin of -463.91% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 38.80 in the most recent quarter. The quick ratio stood at 38.80, with a Debt/Eq ratio of 0.04.